Navigation Links
European membrane expertise to focus on new treatments for human diseases
Date:3/18/2008

A new 15 million Euro project led by the University of Leeds aims to find novel treatments for many human diseases by bringing together the leading European experts in membrane proteins.

The project the European Drug Initiative for Channels and Transporters (EDICT) will target about 80 proteins, which play an important role in human diseases as varied as diabetes, heart disease, neuropsychiatric disorders like epilepsy and depression, osteoporosis, stomach ulcers and cataracts.

Membrane proteins are key to every process in the human body, channelling ions or transporting chemicals and so are ideal targets for new treatments. Infections by pathogenic bacteria, yeasts and parasites also involve their own membrane proteins, which can be specific targets for development of new drugs and antibiotics.

The research is mainly funded by the European Commission, involves twenty-seven partners from twelve countries including two Nobel Laureates - and is set to last four years.

Coordinating the project is Peter Henderson, Professor of Biochemistry and Molecular Biology from Leeds Faculty of Biological Sciences.

Membrane proteins are seen by many as the next potential source of drug development, and so the EC is keen to fund research in this area, he said. However, they are difficult to study and are poorly understood, though the recent sequencing of the human and other genomes show they make up about one third of all proteins in all organisms, including humans.

At the moment, few groups of membrane proteins are being seriously investigated by the pharmaceutical industry, so this project will help to fill that gap. By bringing together the best scientists in this challenging field from all over Europe, we hope to make a real advance towards new treatments for key diseases.

Industry has also seen the benefit of bringing such expertise together under one umbrella and working with the academics will be pharmaceu
'/>"/>

Contact: Jo Kelly
jokelly@campuspr.co.uk
44-113-258-9880
University of Leeds
Source:Eurekalert

Page: 1 2

Related biology news :

1. ESFs European ice core project EPICA receives prestigious Descartes Prize
2. First European Lung Cancer Conference
3. European Union forests expanding, absorbing carbon at surprisingly high rate: study
4. IdentiPHI Opens Paris Office to Boost European Sales and Support
5. Hot spots the key to controlling European carp in Australia
6. European lead in reading past climates from ice cores
7. Three-way mating game of North American lizard found in distant European relative
8. 2 French scientists win European award for communication
9. Last chance for media to register for ECCO 14 -- the European Cancer Conference
10. Researchers develop better membranes for water treatment, drug delivery
11. New membrane strips carbon dioxide from natural gas faster and better

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., 2009) New research on bacterial communities thr...predictable temporal patterns, suggesting that sci... monitoring climate change in the polar regions. T...of the National Academy of Sciences Early Edition...rs shifted synchronously over time, correlating wi...
(Date:11/23/2009)...nity-associated strain of the deadly superbug MRSA...mmon antibioticsposes a far greater health threat ...ospitals, according to a study in the December iss... threat is easily picked up in fitness centers, sc...he overall burden of MRSA within hospitals, the re...
(Date:11/23/2009)...fe Conservation Society says that western lowland ...f Congopart of the "mother lode" of more than 125,...easingly threatened by growing humans activity in ... the swamp forests adjacent to the southwest borde... confirmed that high densities of the great apes s...
Breaking Biology News(10 mins):Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2New study finds MRSA on the rise in hospital outpatients 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Science Under Siege 9241 1Science Under Siege 9241 2Cant Text Im Driving 21 51509 1Cant Text Im Driving 21 51509 2Americans Wary of Health Legislation 3A University of Texas Zogby Poll to be Released on July 15 National Press Club to Host 22NEWSMAKER 22 Media 51505 1
...n by manipulating the neurotransmitter serotonin i...em in ways that are not yet understood, say scient... a Canadian research institute. , That,s because t...erotonin is passed between key cells in the immune...d to activate an immune response. They do not know...
...d geese (Anser brachyrhynchus) prepare for their s...rctic, ecologists are warning that the escalating ...ing the birds, survival. Writing in the new issue ...lied Ecology, Professor Marcel Klaassen of the Net...nal action is urgently required. , Farmers in nort...
... at Northwestern University have developed a novel...d to suppress brain cell inflammation and neuron l...pound is also rapidly absorbed by the brain and is... nervous system drug that might need to be taken f...1 issue of the Journal of Neuroscience, the compou...
Other Biology News:Commonly used antidepressants may also affect human immune system 2Commonly used antidepressants may also affect human immune system 3Spring migration of pink-footed geese under threat 2New compound stops brain cell degeneration in Alzheimer's disease 2New compound stops brain cell degeneration in Alzheimer's disease 3
(Date:11/24/2009)..., HOUSTON,Nov.24/PRNewswire-FirstCall/--IES(Nasd...communicationssystemsandservicesforthecommercial,i...tscommercialbusinessgrouphasbeenawardedacontractfr...rtheLevel4bio-safetylab(BSL-4)replacementfacilitya...seases(USAMRIID)atFortDetrickinFrederick,Md. ,,...
(Date:11/24/2009)..., CALGARYandBLENHEIM,Ontario,Nov.24/PRNewswire-F...acquiringtheassetsofHylandSeeds,adivisionofThompso...dswillfurtherexpandDowAgroSciences,currentseedsbus...tStax(TM) in 2010 andDowAgroSciencesHerbicideTol...loseisexpectedinthenearfuture. ,, "Thisacquisit...
(Date:11/24/2009)..., REYKJAVIK,Iceland,November24/PRNewswire-FirstC...uncedtheapprovalofallofits,"firstday"motionsbytheU...nkruptcyCourt").deCODElastweekfiledavoluntarypetit...ptcyCodewiththe,BankruptcyCourt. , Theordersi...,tooperateitsbusinessduringtheChapter11proceedings...
(Date:11/24/2009)..., SEATTLE,Nov.24/PRNewswire/--BlueMarbleEnergyCo...evelopmentAuthority(OPDA)wererecentlyawarded$2mill...ionBoard(CERB)inaprivate/publicpartnershiptoconstr...nLincolnCounty,WA. ,, "Thisinvestmentwillsignif...over70greenjobstoLincolnCounty,"saidBlueMarbleEner...
Breaking Biology Technology:Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2
...an. 28 Arno Therapeutics, Inc., a,privately held ...tered into,worldwide, exclusive license agreements...ghts to commercially develop novel, orally availab...e license agreements, Arno acquired the rights to ...r, including OSU-03012 (NSC,D728209) and OSU-HDAC4...
...ngs biotech and large pharma experience to lead ... R&D company, BALTIMORE, Jan. 28 Profectus BioSc... preventative and therapeutic,technologies to redu...today,announced that its board of directors has ap...sident and chief executive officer. O,Brien will a...
... Neuroprotective Effect in Preclinical Model of ...ISSAUGA, ON, Jan. 28 /PRNewswire-FirstCall/ - Vaso... company engaged in the research and,commercial de...ructive,inflammatory process associated with the d...eurodegenerative disorders, today announced the,pu...
Other Biology Technology:Arno Therapeutics Completes License Agreements for the Exclusive Rights to Novel, Targeted Cancer Compounds 2Arno Therapeutics Completes License Agreements for the Exclusive Rights to Novel, Targeted Cancer Compounds 3Profectus BioSciences Inc. Names Shawn Patrick O'Brien CEO 2Profectus BioSciences Inc. Names Shawn Patrick O'Brien CEO 3Vasogen's Research Published in European Journal of Neuroscience 2Vasogen's Research Published in European Journal of Neuroscience 3Vasogen's Research Published in European Journal of Neuroscience 4Vasogen's Research Published in European Journal of Neuroscience 5
Mouse Anti-Human ENTPD5 Monoclonal Antibody, Unconjugated, Clone 4A5 from Abnova Corporation
Mouse Anti-Human CHD8 Monoclonal Antibody, Unconjugated, Clone 2C8 from Abnova Corporation
Mouse Anti-Human SYT4 Polyclonal Antibody, Unconjugated from Abnova Corporation
Mouse Anti-Human SNAPC5 Monoclonal Antibody, Unconjugated, Clone 6G10 from Abnova Corporation
Biology Products: